While initially, following treatment, CD8-depleted mice exhibited delayed tumor growth compared to mice treated with Cy alone, ultimately CD8-depleted mice had significantly increased tumor burden relative to treated mice without depletion (Fig. 7f,g). The gene discussed is CD8A; the disease is neoplasm.